Financing: Page 3

Pictor launches $5M financing round to support product, market development

Pictor's multiplex technology enables testing for multiple diseases or different stages of a disease within a single enzyme-linked immunosorbent assay (ELISA) test well.

December 5, 2022

PictorLabs closes $15.2M financing to develop AI-based virtual staining platform

With the additional funds secured in the latest round of financing, PictorLabs intends to expand its biomarker portfolio and develop its products.

December 1, 2022

Sherlock Biosciences secures funding to further develop CRISPR testing platform

The company said it will use the funding to further develop its CRISPR testing platform, enabling broader testing in low- and middle-income countries.

November 29, 2022

Empatica receives FDA clearance for digital biomarker platform, closes Series B financing

The platform is used to gather and analyze physiological data for clinical trials evaluating new therapeutics. Empatica is collaborating with researchers on digital biomarkers for use as endpoints.

November 23, 2022

Biodesix secures loan of up to $50M, announces $35.1M stock offering

The developer of diagnostic tests that combine multiomics through AI said it will use the loan to strengthen its balance sheet, reduce near-term cash use, and enable the continued growth trajectory of its core lung diagnostics business.

November 17, 2022

SQI Diagnostics secures C$2M to support manufacturing, commercialization

SQI will use the funds to support its manufacturing scale-up and commercialization of its pipeline of products in development, including the Rali-Dx IL-6 test.

November 10, 2022

Virax Biolabs closes $3.8M private placement to support development of T-cell testing technology

Virax said it will use the net proceeds from the private placement to develop and commercialize its T-cell test technology.

November 9, 2022

Osler Diagnostics raises $85M in Series C financing

Osler Diagnostics said that the Series C financing will support its portable testing platform, which aims to provide a broad menu of tests.

November 7, 2022

Guardant Health reports 24% rise in third-quarter revenue

Guardant’s third-quarter revenue was $117.4 million, a 24% increase over $94.8 million for the third quarter of 2021.

November 4, 2022

Veracyte announces Q3 financial results

Veracyte's third-quarter total revenue was $75.6 million, 25% higher than 2021’s third-quarter revenue of $60.4 million.

November 3, 2022

Surmodics enters $125 million financing agreement with MidCap Financial

The proceeds were partially used to retire its $25 million revolving credit facility with Bridgewater Bank, of which $10 million was outstanding.

October 17, 2022

Multiomics firm Pleno closes $40 million Series A financing

Pleno said its enabling technology leverages signal processing techniques from telecom to deliver ultra-high plexity, targeted biological information at high throughput.

October 12, 2022

Previous Page

Page 3 of 6

Next Page